Sangers (northern Ireland) Limited

POWER SEARCH PRICING

SOLUTIONS

sangers (northern ireland) limited Company Information

Live

MatureLargeHealthy

Company Number

NI018941

Website

http://www.aah.co.uk

Registered Address

2 marshalls road, belfast, bt5 6sr, BT5 6SR

Industry

Wholesale of pharmaceutical goods

Telephone

02890401111

Next Accounts Due

December 2024

Group Structure

View All

Directors

Peter Surgenor21 Years

Wendy Hall1 Years

View All

Shareholders

aah pharmaceuticals limited 100%

sangers (northern ireland) limited Estimated Valuation

£13m - £46.7m

The estimated valuation range for sangers (northern ireland) limited, derived from financial data as of March 2023 and the most recent industry multiples, is between £13m to £46.7m

Get a detailed valuation report, edit figures and unlock valuation multiples.

Sangers (northern Ireland) Limited AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Sangers (northern Ireland) Limited is a live company located in bt5 6sr, BT5 6SR with a Companies House number of NI018941. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in May 1985, it's largest shareholder is aah pharmaceuticals limited with a 100% stake. Sangers (northern Ireland) Limited is a mature, large sized company, Pomanda has estimated its turnover at £48.9m with healthy growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Sangers (Northern Ireland) Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 1 areas for improvement. Company Health Check FAQs

Health Rating5out of 5

6 Strong

4 Regular

1 Weak

Size

annual sales of £48.9m, make it larger than the average company (£25.3m)

Growth

3 year (CAGR) sales growth of 6%, show it is growing at a similar rate (4.9%)

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for sangers (northern ireland) limited. Get real-time insights into sangers (northern ireland) limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for sangers (northern ireland) limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

SANGERS (NORTHERN IRELAND) LIMITED group structure

Sangers (Northern Ireland) Limited has 3 subsidiary companies.

Ultimate parent company

AURELIUS INVESTMENT LUX ONE SARL

#0143598

AAH PHARMACEUTICALS LIMITED

00123458

2 parents

SANGERS (NORTHERN IRELAND) LIMITED

NI018941

3 subsidiaries

PRIMA BRANDS LIMITED

NI010262

BLACKSTAFF PHARMACEUTICALS LIMITED

03754932

J. BRADBURY (SURGICAL) LIMITED

NI035736

SANGERS (NORTHERN IRELAND) LIMITED Shareholders

aah pharmaceuticals limited

100%

Sangers (Northern Ireland) Limited currently has 5 directors. The longest serving directors include Mr Peter Surgenor (Jan 2003) and Mrs Wendy Hall (Jul 2022).

officer	country	age	start	end	role
Mr Peter Surgenor		66 years	Jan 2003	-	Director
Mrs Wendy Hall	United Kingdom	53 years	Jul 2022	-	Director
Ms Wendy Hall	England	53 years	Jul 2022	-	Director
Mr David Bound	England	62 years	Dec 2022	-	Director
Mr Adrian Stubbings		51 years	Feb 2024	-	Director

EXPORT

Sangers (Northern Ireland) Limited's latest turnover from March 2023 is £48.9 million and the company has net assets of £14.2 million. According to their latest financial statements, we estimate that Sangers (Northern Ireland) Limited has 78 employees and maintains cash reserves of £3 million as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Turnover	48,945,226	47,443,123	38,338,194	41,658,505	39,755,005	70,432,948	245,462,215	197,296,342	220,885,331	225,611,650	223,284,365	215,393,280	213,988,221	199,848,741
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	43,413,416	41,985,364	33,357,164	35,834,345	34,604,931	63,012,885	225,103,481	182,024,256	205,961,497	211,153,944	209,698,466	202,368,820	201,543,160	188,147,951
Gross Profit	5,531,810	5,457,759	4,981,030	5,824,160	5,150,074	7,420,063	20,358,734	15,272,086	14,923,834	14,457,706	13,585,899	13,024,460	12,445,061	11,700,790
Admin Expenses	3,830,497	3,955,571	2,512,007	2,102,934	1,960,755	6,031,757	20,094,646	10,895,900	10,135,812	9,633,145	7,289,372	8,153,658	7,771,174	7,338,884
Operating Profit	1,701,313	1,502,188	2,469,023	3,721,226	3,189,319	1,388,306	264,088	4,376,186	4,788,022	4,824,561	6,296,527	4,870,802	4,673,887	4,361,906
Interest Payable	0	0	0	9,907	201,814	281,194	683,240	822,000	1,010,027	1,693,532	1,958,148	1,842,123	1,730,706	2,782,847
Interest Receivable	241,430	115	11,143	68,180	36,405	0	9,275	643,387	696,971	699,774	741,611	2,708,532	1,759,008	673,099
Pre-Tax Profit	1,942,743	1,502,303	2,480,166	3,779,499	3,023,910	1,107,112	-2,550,069	4,290,573	77,642,600	6,926,888	8,579,990	5,737,211	4,702,189	3,510,733
Tax	753,512	-268,603	-470,286	-615,183	-506,175	-689,714	593,134	-901,766	-803,049	-713,239	-1,169,216	-1,253,118	-1,229,306	-498,978
Profit After Tax	2,696,255	1,233,700	2,009,880	3,164,316	2,517,735	417,398	-1,956,935	3,388,807	76,839,551	6,213,649	7,410,774	4,484,093	3,472,883	3,011,755
Dividends Paid	0	0	0	0	0	0	10,050,000	1,000,000	76,166,485	3,750,000	6,000,000	3,000,000	2,000,000	0
Retained Profit	2,696,255	1,233,700	2,009,880	3,164,316	2,517,735	417,398	-12,006,935	2,388,807	673,066	2,463,649	1,410,774	1,484,093	1,472,883	3,011,755
Employee Costs	0	0	0	0	0	2,913,857	10,829,340	7,144,330	6,581,898	6,703,521	4,964,355	6,580,827	6,209,762	5,853,166
Number Of Employees	78	78	63	72	68	84	206	216	223	227	235	230	277	269
EBITDA*	1,701,313	1,502,188	2,469,023	3,721,226	3,189,319	1,849,135	2,427,267	5,549,390	5,921,428	5,851,139	7,039,221	5,693,877	5,613,149	5,237,567

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Tangible Assets	0	0	0	0	0	0	9,739,110	12,969,297	12,572,664	12,750,787	10,757,145	8,063,106	8,031,136	8,317,830
Intangible Assets	0	0	0	0	0	0	224,891	32,094	39,500	46,906	54,312	61,720	69,126	76,532
Investments & Other	776,902	776,905	777,902	777,902	852,704	777,903	2,252,242	1,267,236	777,907	978,406	978,406	978,406	978,406	978,406
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	776,902	776,905	777,902	777,902	852,704	777,903	12,216,243	14,268,627	13,390,071	13,776,099	11,789,863	9,103,232	9,078,668	9,372,768
Stock & work in progress	6,726,832	5,628,463	6,509,623	3,995,117	4,702,687	3,596,009	7,231,610	11,295,743	11,543,361	11,998,748	11,982,177	13,523,888	11,480,231	10,398,396
Trade Debtors	4,760,502	5,058,451	3,268,187	5,012,403	4,330,277	4,349,039	16,801,514	29,823,362	34,469,578	38,252,843	37,529,851	37,467,050	37,643,375	37,285,798
Group Debtors	4,131,304	4,299,862	1,266,995	1,216,148	2,054,720	3,730,386	1,951,740	3,136,894	4,031,058	10,186,940	10,336,174	10,564,157	8,110,459	7,106,023
Misc Debtors	4,598,100	3,492,634	3,830,833	3,229,950	2,069,815	2,050,730	2,686,515	1,744,243	2,429,661	1,941,060	3,721,781	4,226,075	4,781,081	7,022,397
Cash	2,967,347	1,308,151	6,203,307	4,667,934	7,528,468	7,717,498	9,748,122	15,604,537	11,599,844	9,908,629	9,076,043	9,918,678	10,447,973	5,882,069
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	23,184,085	19,787,561	21,078,945	18,121,552	20,685,967	21,443,662	38,419,501	61,604,779	64,073,502	72,288,220	72,646,026	75,699,848	72,463,119	67,694,683
total assets	23,960,987	20,564,466	21,856,847	18,899,454	21,538,671	22,221,565	50,635,744	75,873,406	77,463,573	86,064,319	84,435,889	84,803,080	81,541,787	77,067,451
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	7,574,353	6,082,989	7,064,482	5,091,247	6,129,943	4,625,568	16,909,980	29,472,354	31,366,153	31,978,205	30,421,110	29,819,168	26,509,636	25,405,454
Group/Directors Accounts	304,528	308,673	2,296,180	3,391,672	8,653,706	14,450,036	24,157,260	24,707,034	24,746,310	33,557,616	34,232,198	34,268,411	35,102,568	33,044,458
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	1,849,814	2,636,767	2,193,848	2,124,078	1,626,881	535,555	2,952,446	3,624,047	6,192,599	5,899,584	7,372,836	8,468,034	9,140,894	9,238,097
total current liabilities	9,728,695	9,028,429	11,554,510	10,606,997	16,410,530	19,611,159	44,019,686	57,803,435	62,305,062	71,435,405	72,026,144	72,555,613	70,753,098	67,688,009
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	86,050	120,066	0	0	0	0	0	0
total long term liabilities	0	0	0	0	0	0	4,423,050	2,528,066	2,020,500	1,247,500	2,312,350	2,635,000	2,577,880	1,836,880
total liabilities	9,728,695	9,028,429	11,554,510	10,606,997	16,410,530	19,611,159	48,442,736	60,331,501	64,325,562	72,682,905	74,338,494	75,190,613	73,330,978	69,524,889
net assets	14,232,292	11,536,037	10,302,337	8,292,457	5,128,141	2,610,406	2,193,008	15,541,905	13,138,011	13,381,414	10,097,395	9,612,467	8,210,809	7,542,562
total shareholders funds	14,232,292	11,536,037	10,302,337	8,292,457	5,128,141	2,610,406	2,193,008	15,541,905	13,138,011	13,381,414	10,097,395	9,612,467	8,210,809	7,542,562

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Operating Activities
Operating Profit	1,701,313	1,502,188	2,469,023	3,721,226	3,189,319	1,388,306	264,088	4,376,186	4,788,022	4,824,561	6,296,527	4,870,802	4,673,887	4,361,906
Depreciation	0	0	0	0	0	419,896	2,131,085	1,165,798	1,126,000	1,019,172	735,286	815,669	931,856	868,255
Amortisation	0	0	0	0	0	40,933	32,094	7,406	7,406	7,406	7,408	7,406	7,406	7,406
Tax	753,512	-268,603	-470,286	-615,183	-506,175	-689,714	593,134	-901,766	-803,049	-713,239	-1,169,216	-1,253,118	-1,229,306	-498,978
Stock	1,098,369	-881,160	2,514,506	-707,570	1,106,678	-3,635,601	7,231,610	-247,618	-455,387	16,571	-1,541,711	2,043,657	1,081,835	10,398,396
Debtors	638,959	4,484,932	-1,092,486	1,003,689	-1,675,343	-11,309,614	21,439,769	-6,225,798	-9,450,546	-1,206,963	-669,476	1,722,367	-879,303	51,414,218
Creditors	1,491,364	-981,493	1,973,235	-1,038,696	1,504,375	-12,284,412	16,909,980	-1,893,799	-612,052	1,557,095	601,942	3,309,532	1,104,182	25,405,454
Accruals and Deferred Income	-786,953	442,919	69,770	497,197	1,091,326	-2,416,891	2,952,446	-2,568,552	293,015	-1,473,252	-1,095,198	-672,860	-97,203	9,238,097
Deferred Taxes & Provisions	0	0	0	0	0	-86,050	86,050	120,066	0	0	0	0	0	0
Cash flow from operations	1,421,908	-2,908,761	2,619,722	2,268,425	5,847,510	1,317,283	-5,702,502	6,778,755	14,705,275	6,412,135	7,587,936	3,311,407	5,188,290	-22,430,474
Investing Activities
capital expenditure	0	0	0	0	0	9,503,172	-12,127,180	-1,562,431	-947,877	-3,012,814	-3,429,325	-847,639	-645,162	-9,270,023
Change in Investments	-3	-997	0	-74,802	74,801	-1,474,339	2,252,242	489,329	-200,499	0	0	0	0	978,406
cash flow from investments	3	997	0	74,802	-74,801	10,977,511	-14,379,422	-2,051,760	-747,378	-3,012,814	-3,429,325	-847,639	-645,162	-10,248,429
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	-4,145	-1,987,507	-1,095,492	-5,262,034	-5,796,330	-9,707,224	24,157,260	-39,276	-8,811,306	-674,582	-36,213	-834,157	2,058,110	33,044,458
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	0	0	0	0	14,199,943	15,087	-916,469	820,370	-925,846	-82,435	-804,636	4,530,807
interest	241,430	115	11,143	58,273	-165,409	-281,194	-673,965	-178,613	-313,056	-993,758	-1,216,537	866,409	28,302	-2,109,748
cash flow from financing	237,285	-1,987,392	-1,084,349	-5,203,761	-5,961,739	-9,988,418	37,683,238	-202,802	-10,040,831	-847,970	-2,178,596	-50,183	1,281,776	35,465,517
cash and cash equivalents
cash	1,659,196	-4,895,156	1,535,373	-2,860,534	-189,030	-2,030,624	9,748,122	4,004,693	1,691,215	832,586	-842,635	-529,295	4,565,904	5,882,069
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	1,659,196	-4,895,156	1,535,373	-2,860,534	-189,030	-2,030,624	9,748,122	4,004,693	1,691,215	832,586	-842,635	-529,295	4,565,904	5,882,069

P&L

March 2023

turnover

48.9m

+3%

operating profit

1.7m

+13%

gross margin

11.4%

-1.75%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

14.2m

+0.23%

total assets

24m

+0.17%

cash

+1.27%

net assets

Total assets minus all liabilities

Similar Companies

Agree?

strathclyde pharmaceuticals limited

donald wardle and son limited

n.g. limited

respond healthcare limited

chemilines group holdings limited

company number

NI018941

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

incorporation date

May 1985

age

accounts

Full Accounts

ultimate parent company

AURELIUS INVESTMENT LUX ONE SARL

previous names

N/A

incorporated

address

2 marshalls road, belfast, bt5 6sr, BT5 6SR

last accounts submitted

March 2023

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 3 charges/mortgages relating to sangers (northern ireland) limited. Currently there are 1 open charges and 2 have been satisfied in the past.

sangers (northern ireland) limited Company Information

sangers (northern ireland) limited Estimated Valuation

sangers (northern ireland) limited Estimated Valuation

sangers (northern ireland) limited Estimated Valuation

Sangers (northern Ireland) Limited AI Business Plan

Sangers (northern Ireland) Limited Overview

Sangers (northern Ireland) Limited Health Check

sangers (northern ireland) limited Credit Report and Business Information

Sangers (northern Ireland) Limited Competitor Analysis

sangers (northern ireland) limited Ownership

sangers (northern ireland) limited directors

SANGERS (NORTHERN IRELAND) LIMITED financials

sangers (northern ireland) limited company details

sangers (northern ireland) limited Charges & Mortgages

sangers (northern ireland) limited Companies House Filings - See Documents